Song Yuguo, Wang Dixin, Li Huiling, Hao Fengtong, Ma Jing, Xia Yujing
Department of Occupational Diseases and Clinical Toxicology, Beijing Chaoyang Hospital, Beijing, People's Republic of China.
Clin Toxicol (Phila). 2007 Sep;45(6):721-7. doi: 10.1080/15563650701502675.
Exposure to arsine gas can cause fatal hemolysis and multiorgan damage. Whole blood exchange transfusion and hemodialysis have been recommended to treat severe acute arsine poisoning, but are associated with significant complications and sub-optimal outcomes. Plasma exchange is another method of blood purification technique but there are no data on its use in acute arsine poisoning. This retrospective study evaluated the clinical and effects and arsenic clearance from the use of plasma exchange treatment of patients with acute arsine poisoning.
Data from patients with severe acute arsine poisoning, treated with plasma exchange from December 2000 to December 2005 were collected and analyzed. Measured laboratory factors, performed before and after plasma exchange treatment included routine biochemistry and hematology tests as well as arsenic concentrations in blood, urine, and discarded plasma.
During the study period, 12 patients with severe acute arsine poisoning were treated with plasma exchange. Plasma exchange was performed one or two times on each patient, during which the replacement fluid was fresh frozen plasma (total volume ranged from 1,400 to 4,000 mL). The range of concentrations of arsenic in discarded plasma was 27.7 to 88.7 mg/L and the range of total arsenic removed by plasma exchange was 55.4 to 177.4 mg. Plasma exchange appears to rapidly terminate arsine-induced hemolysis and favorably modify damage to the kidneys and other organs. Laboratory factors that showed significant association with treatment response were creatine kinase, lactate dehydrogenase, blood urea nitrogen, total bilirubin, and heart-related enzymes. All patients recovered from the poisoning and were in good condition at a 2 to 3 months follow-up.
Plasma exchange appears to be an effective treatment intervention for patients with severe acute arsine poisoning. It is suggested that it be used as early as possible.
接触砷化氢气体可导致致命的溶血和多器官损害。推荐采用全血交换输血和血液透析治疗严重急性砷化氢中毒,但这些方法会引发严重并发症且效果欠佳。血浆置换是另一种血液净化技术,但尚无其用于急性砷化氢中毒的相关数据。本回顾性研究评估了血浆置换治疗急性砷化氢中毒患者的临床疗效及砷清除情况。
收集并分析2000年12月至2005年12月期间接受血浆置换治疗的严重急性砷化氢中毒患者的数据。在血浆置换治疗前后检测的实验室指标包括常规生化和血液学检查,以及血液、尿液和废弃血浆中的砷浓度。
研究期间,12例严重急性砷化氢中毒患者接受了血浆置换治疗。每位患者进行了一或两次血浆置换,置换液为新鲜冰冻血浆(总量为1400至4000毫升)。废弃血浆中砷的浓度范围为27.7至88.7毫克/升,血浆置换清除的总砷量范围为55.4至177.4毫克。血浆置换似乎能迅速终止砷化氢诱导的溶血,并有效改善对肾脏和其他器官的损害。与治疗反应显著相关的实验室指标有肌酸激酶、乳酸脱氢酶、血尿素氮、总胆红素和心脏相关酶。所有患者均从中毒中康复,在2至3个月的随访中情况良好。
血浆置换似乎是治疗严重急性砷化氢中毒患者的有效干预措施。建议尽早使用。